1. Home
  2. EFOI vs QNCX Comparison

EFOI vs QNCX Comparison

Compare EFOI & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EFOI

Energy Focus Inc.

HOLD

Current Price

$2.71

Market Cap

21.0M

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

N/A

Current Price

$34.19

Market Cap

17.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EFOI
QNCX
Founded
1985
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.0M
17.5M
IPO Year
2004
2019

Fundamental Metrics

Financial Performance
Metric
EFOI
QNCX
Price
$2.71
$34.19
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
7.8K
30.3K
Earning Date
05-12-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
43.75
N/A
EPS
N/A
N/A
Revenue
$3,560,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.66
$0.08
52 Week High
$9.84
$35.41

Technical Indicators

Market Signals
Indicator
EFOI
QNCX
Relative Strength Index (RSI) 39.80 75.38
Support Level $1.98 $0.89
Resistance Level $2.79 N/A
Average True Range (ATR) 0.12 2.62
MACD -0.03 -0.06
Stochastic Oscillator 20.23 83.04

Price Performance

Historical Comparison
EFOI
QNCX

About EFOI Energy Focus Inc.

Energy Focus Inc specializes in designing, developing, manufacturing, and selling energy-efficient lighting systems and controls. It provides LED lighting solutions for both commercial and military maritime markets (MMM). Its core products include robust lighting fixtures and lamps for navy and military applications, Energy Storage Systems (ESS), Uninterruptible Power Supply (UPS), and tubular LED (TLED) lighting products, including battery backup units as well as general commercial and maritime lighting fixtures. The company operates in a single business segment that includes the marketing and sale of commercial and MMM lighting products and controls. The company generates a majority of its revenue from the sales of military maritime products in the United States.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.

Share on Social Networks: